[ASAP] Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.8b00808

Source: Journal of Medicinal Chemistry - July 30, 2018 Category: Chemistry Authors: Ryo Iwamura, Masayuki Tanaka, Eiji Okanari, Tomoko Kirihara, Noriko Odani-Kawabata, Naveed Shams, Kenji Yoneda Source Type: research